Marshall Fordyce describes the rationale of targeting both BAFF and APRIL as a B-cell modulator for IgAN, highlights 72 week data Vera released in January, and discusses the potential path to market in this space.
Also look for unique social pages for BiotechTV U.
HSBC Innovation Banking's dedicated sector experts possess in-depth knowledge of the technology, life science and healthcare economies. With access to an extensive global network, we can help you fuel growth through venture capital and corporate investors, industry influencers, customers, and global opportunities.
Through our interconnected innovation hubs in the US, UK, Israel and Hong Kong, our experts are supporting the world’s innovation economy – both clients and their investors to help them meet their growth goals.
.png){kind=logo}